HOME       Contact Us      Hire Us       Domestic Airlines        Railway Enquiry     Railway Booking     Hotels & Flights Abroad
NEIGHBOURS CALLING:      Dubai      Malaysia     Nepal     Bhutan
indiatraveltimes.com
COVID DATA October 19, 2021 INDIA: New Cases: 13,058 Total Cases: 3,40,94,373 New Deaths: 164 Total Deaths: 4,52,454 New Tests: 11,81,314 Total Tests: 59,31,06,188 New Vax: 87,41,160 Total Vax: 98,67,69,411 Hot Spot States (daily deaths above 10) Karnataka: New Deaths: 12 Total Deaths: 37,953 Kerala: New Deaths: 60 Total Deaths: 26,925 TPR: 9.72% Maharashtra: New Deaths: 27 Total Deaths: 1,39,816 Tamil Nadu: New Deaths: 13 Total Deaths: 35,912 Bengal: New Deaths: 12 Total Deaths: 18,989 - India Travel Times.Com   [Estd: 1998]       * * *    Travel, More Travel, Travel Means A Million Things     * * *    
Fake Covishield covid vaccine detected, WHO issues alert
The WHO has issued an alert against fake Covishield supplies in India and Uganda. Serum Institute of India has confirmed the finding. The Indian Government is investigating. The WHO said the products identified misrepresent their identity, composition and source. While the fake Covishield circulated in India is of 2 ml vial (4 doses), the vaccine manufacturer produces it in standard 5 ml vials. In the case of Uganda, the the expiry date (10.08.2021) on the product was falsified.

NEW DELHI, Aug 18: The World Health Organisation (WHO) has issued an alert against fake Covishield covid vaccine in supply in India and Uganda.

Covishield is the Indian version of the Oxford-AstraZeneca vaccine produced under licence in India by Serum Institute of India (SII), Pune. The SII is the largest vaccine producer in the world. According to the WHO, the SII has confirmed that the existence of fake supplies. These counterfeits came to light in the months of July and August.

The WHO alert said falsified covid vaccines pose a serious risk to global public health and place an additional burden on vulnerable populations and health systems. It is important to detect and remove these falsified products from circulation to prevent harm to patients.

It said the products identified misrepresent their identity, composition or source:-

COVISHIELD 2ml (circulated in India): The genuine manufacturer does not produce COVISHIELD in 2ml (4 doses).

Batch 4121Z040 (circulated in Uganda): The expiry date (10.08.2021) on this product is falsified

WHO called for increased vigilance in countries likely to be affected by fake products. "Increased vigilance should include hospitals, clinics, health centres, wholesalers, distributors, pharmacies, and any other suppliers of medical products," it said.

The Indian health ministry is investigating the matter. It has not received any complaints so far. However, there are no details about the fake vaccines the WHO claims to have detected in India either.

Another vaccine scam was recently unearthed in Maharashtra where saline water was injected in place of vaccine. An inquiry is on.

India began its mega vaccination drive on January 16 last. Covishield and Covaxin are the main vaccines being used in India. As of August 17, India has administered 55.47 crore doses overall. About 13% of the population has been fully vaccinated. In the case of all the vaccines available so far, except Johnson & Johnson's Janssen which is a single-dose vaccine, one has to receive two doses with a certain gap of a few weeks depending on the vaccine make, to get oneself fully immunised.

Each genuine 5 ml vial of Covishield vaccine has 10 doses in total. (And, once opened, all the 10 doses have to be consumed within four hours, else the remaining doses will go waste and will have to be destroyed.) Indigenously produced Covaxin of Bharat Biotech was in 20-dose vials initially which was changed to 10-dose later for the convenience of administration. Worldwide, both 10-dose and 20-dose vials are used in public health immunization programmes.

Inoculation of vial overfill volume is a malpractice only when residual vaccine from multiple vials are combined to form a dose

Usually in multi-dose vials there can be an excess of volume to cover for wastage. This depends on several factors such as syringe dead space, vial overfill volume and technique and accuracy of doses withdrawn and delivered. Syringe dead space is the volume of vaccine left in the syringe after administration. Manufacturers provide extra vaccine to aid health workers in proper administration.

Filling extra vaccine in a vial is a common practice in vaccine production and is called ‘overfill’. Overfill for a 10-dose vial can be from about 16% to 24% . So it is possible to withdraw 11 or 12 doses of 0.5 mL from a 10-dose vial.

If the vaccinator can withdraw additional accurate vaccine dose (s) after having withdrawn the number of doses listed on a vial label, it can be administered, says the WHO.

But if an accurate dose is not available, do not combine residual vaccine from multiple vials.

Pre-loading of syringes is also not recommended.

Previous Files
ARCHIVES



Neighbours
Calling

Bhutan
Nepal
Malaysia
Dubai

Dera Sacha Sauda chief Gurmeet Ram Rahim sentenced to life term in jail for murder
Kaleekkal Madom N Parameswaran Namboothiri is new head priest of Sabarimala temple
As rains continue, no pilgrims to be allowed to trek to Sabarimala temple
Reliance Brands acquires 40% stake in luxury designer Manish Malhotra's MM Styles

Fashion & Lifestyle
Cuisines
Yoga & Asanas
Fairs, Festivals & Melas
Religion & Cult
Pilgrimage
Art & Culture
History, Legends & Mythology
Ayurveda
Free Ayurveda Consultation
ARCHIVES
A Window On India
Fashion & Lifestyle
Yoga & Asanas
Fairs, Festivals & Melas
Religion & Cult
Pilgrimage
Art & Culture
History, Legends & Mythology
Ayurveda
News (Archives)
Travel News
Travel News Archives
Travel News Index

Custom Search